Product
Truvada
Aliases
Emtricitabine/Tenofovir Disoproxil Fumarate, FTC/TDF, TRUVADA™ or EPZICOM™/KIVEXA™, Truvada Tablet
Name
Truvada
INN Name
emtricitabine and tenofovir disoproxil fumarate
FDA Approved
Yes
13 clinical trials
5 organizations
19 indications
1 document
Indication
HIV-1Indication
HIVIndication
ProphylaxisIndication
Gender dysphoriaIndication
HIV InfectionIndication
AdherenceIndication
MedicationIndication
TherapyIndication
Pre-exposure ProphylaxisIndication
Antiretroviral TherapyIndication
Pre-Exposure Prophylaxis (PrEP)Indication
HIV InfectionsIndication
Multiple SclerosisIndication
HIV infectionIndication
Opioid UseIndication
Opioid Use DisorderIndication
Risk ReductionIndication
Hepatitis CIndication
HIV-1 InfectionClinical trial
A Phase 3 Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Doravirine (MK-1439) 100 mg Once Daily Versus Darunavir 800 mg Once Daily Plus Ritonavir 100 mg Once Daily, Each in Combination With TRUVADA™ or EPZICOM™/KIVEXA™, in Treatment-Naïve HIV-1 Infected SubjectsStatus: Completed, Estimated PCD: 2016-09-29
Clinical trial
A Phase I Trial for the Evaluation of the Two-way Pharmacokinetic-pharmacodynamic (PD) Interaction of Gender Affirming Exogenous Estrogen (With Testosterone Suppression) on TDF/FTC PrEP in Transgender Women (TGW)Status: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
ID Cap System: Next Generation Ingestible Sensors for Medication Adherence MeasurementStatus: Recruiting, Estimated PCD: 2024-04-30
Clinical trial
PrEPared-RN, CAN Nurse-Led Management of High-risk Patients for Pre-ExposureStatus: Recruiting, Estimated PCD: 2025-07-10
Clinical trial
Phase 3B, Randomized, Open-Label, Safety, and Drug Detection Study of Dapivirine Vaginal Ring and Oral TRUVADA® in Breastfeeding Mother-Infant PairsStatus: Completed, Estimated PCD: 2021-11-04
Clinical trial
Effects of Antiviral Therapies on Epstein-Barr Virus ReplicationStatus: , Estimated PCD: 2024-06-04
Clinical trial
HPTN 091: Integrating HIV Prevention, Gender-Affirmative Medical Care, and Peer Health Navigation for Transgender Women in the Americas: A Vanguard StudyStatus: Active (not recruiting), Estimated PCD: 2024-09-16
Clinical trial
CHAMPS: Choices For Adolescent Prevention Methods For South Africa. Pilot Study B: 'PlusPills'Status: Completed, Estimated PCD: 2017-03-06
Clinical trial
A Prosp., Multic., Randomized, Open-label Trial to Assess the Safety, Tolerability and Efficacy of Dual Therapy With Boosted Darunavir + Dolutegravir When Switching From SOC ART in HIV-patients With Sustained Virological Suppr.Status: Completed, Estimated PCD: 2018-05-31
Clinical trial
Effects of the Anti-HIV Pill Truvada on Gene Transcription in the Gastrointestinal Tract of HIV-uninfected IndividualsStatus: Completed, Estimated PCD: 2017-12-01
Clinical trial
Providing A Resource: Telemedicine at Needle Exchanges to Reach Under-served Populations - GreensboroStatus: Completed, Estimated PCD: 2023-03-30
Clinical trial
Phase 3b, Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in PregnancyStatus: Active (not recruiting), Estimated PCD: 2024-06-30
Clinical trial
WRHI 060 (ADVANCE): A Randomised, Phase 3 Non-inferiority Study of DTG + TAF + FTC Compared With DTG + TDF + FTC and EFV + TDF + FTC in Patients Infected With HIV-1 Starting First-line Antiretroviral Therapy - Extension to 192 WeeksStatus: Completed, Estimated PCD: 2022-04-30
Document
DailyMed Label: TruvadaOrganization
RedPharm Drug, Inc.Organization
H.J. Harkins Company, Inc.Organization
Gilead Sciences, Inc.Organization
State of Florida DOH Central PharmacyOrganization
A-S Medication Solutions